ID   B78-D14
AC   CVCL_F6L2
RX   PubMed=8755561;
CC   Characteristics: Amelanotic.
CC   Characteristics: Constitutively expresses GD2 and GD3 gangliosides (PubMed=8755561).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4117; B4GALNT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11410; ST8SIA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03072; JC polyomavirus large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F6L1 ! KF3027-Hyg5
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-26; Last updated: 22-10-26; Version: 1
//
RX   PubMed=8755561; DOI=10.1073/pnas.93.15.7826; PMCID=PMC38833;
RA   Becker, J.C.
RA   Varki, N.
RA   Gillies, S.D.
RA   Furukawa, K.
RA   Reisfeld, R.A.
RT   "An antibody-interleukin 2 fusion protein overcomes tumor
RT   heterogeneity by induction of a cellular immune response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7826-7831(1996).
//